Concepedia

Larry Bratton

LB

Statistics

Publications

11

Citations

299

H-Index

11

Active since

1997

Affiliations

Pfizer (United States)(Current)

Larry Bratton is an author at Pfizer (United States) specializing in pharmacology, medicinal chemistry, and drug discovery.

Publications per year

1997–2021

11

Publications

11

Thermodynamic and Structure Guided Design of Statin Based Inhibitors of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase

Ronald W. Sarver, Elizabeth Bills, Gary L. Bolton et al. · Journal of Medicinal Chemistry · 2008 · 65 citations · Full text

, , +17

Design and synthesis of hepatoselective, pyrrole-based HMG-CoA reductase inhibitors

Jeffrey A. Pfefferkorn, Yuntao Song, Kuai-Lin Sun et al. · Bioorganic & Medicinal Chemistry Letters · 2007 · 55 citations · Full text

, , +12

Discovery of pyrrole-based hepatoselective ligands as potent inhibitors of HMG-CoA reductase

Larry Bratton, Bruce J. Auerbach, Chulho Choi et al. · Bioorganic & Medicinal Chemistry · 2007 · 35 citations · Full text

, , +15

Targeting the HuR Oncogenic Role with a New Class of Cytoplasmic Dimerization Inhibitors

Natalia Filippova, Xiuhua Yang, Subramaniam Ananthan et al. · Cancer Research · 2021 · 32 citations · Full text

, , +14

Synthesis and SAR of selective benzothiophene, benzofuran, and indole-based peroxisome proliferator-activated receptor δ agonists

Gary F. Filzen, Larry Bratton, Xue‐Min Cheng et al. · Bioorganic & Medicinal Chemistry Letters · 2007 · 24 citations · Full text

, , +12

1–5 of 11